COMMUNIQUÉS West-GlobeNewswire

CORRECTION: Axovant Announces Negative Results for Intepirdine in Phase 2b HEADWAY and Pilot Phase 2 Gait and Balance Studies; Positive Trends in Efficacy Seen in Pilot Phase 2 Nelotanserin Study

09/01/2018 - 13:00

BASEL, Switzerland, Jan. 09, 2018 (GLOBE NEWSWIRE) -- Axovant Sciences (NASDAQ: AXON ) today announced a correction to the data related to the Company’s investigational drug nelotanserin previously reported in its [...]

FDA Clears Pluristem’s Expanded Access Program to Initiate Treatments of Critical Limb Ischemia Outside of Ongoing Phase III Study

09/01/2018 - 13:00

Program Allows for Collection of Real-World Data Alongside the Company’s Ongoing Phase III Study in CLI FDA May Also Allow Pluristem to Be Compensated for the Cost of Treatment HAIFA, Israel, Jan. 09, 2018 (GLOBE [...]

Transactions in relation to share buyback program

09/01/2018 - 11:50

Acting under its share buyback authorization, the GN Store Nord board of directors initiated a share buyback program on May 4, 2017 in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]

Genetic Technologies Regains Nasdaq Listing Compliance

09/01/2018 - 11:00

MELBOURNE, Australia, Jan. 09, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (Nasdaq: GENE ) (“Company”), is pleased to advise that the Company received a notification letter (the "Notice") from the [...]

Veritas Pharma Provides Comment on U.S. Attorney General Jeff Sessions Memo

09/01/2018 - 09:05

VANCOUVER, British Columbia, Jan. 09, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) and (Frankfurt: 2VP ) , (“Veritas” or the “Company”) provides the following statement to the memorandum issued by [...]

Novartis advances head-to-head superiority trials of Cosentyx® versus Humira®* and proposed biosimilar adalimumab**

09/01/2018 - 07:16

SURPASS is the first head-to-head superiority trial versus proposed biosimilar adalimumab** in ankylosing spondylitis (AS)[1] EXCEED is the first head-to-head superiority trial versus Humira ® * in psoriatic arthritis ( [...]

Cannabis Wheaton Income Corp. Announces Strategic Investment and Alliance With Inner Spirit Holdings Ltd.

09/01/2018 - 06:57

VANCOUVER, British Columbia, Jan. 09, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX-V: CBW ) (" Wheaton Income " or the " Company ") is pleased to announce that it has entered into [...]

Breathtec Biomedical Unaware of Any Material Change

09/01/2018 - 04:43

VANCOUVER, British Columbia, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Breathtec Biomedical, Inc. (CSE:BTH) (OTCQB:BTHCF) (the “ Company ” or “ Breathtec ”) - at the request of the Investment Industry Regulatory Organization of [...]

Quotient Limited Reports Further Positive Data on its Initial Disease Screening Microarray and Provides Update on Blood Grouping

09/01/2018 - 02:15

Performance evaluation studies for the initial disease screening microarray demonstrate 100% sensitivity and >99% specificity for the CMV and Syphilis assays V&V for blood grouping is ongoing – pending a [...]

Cannabis Wheaton Income Corp. Announces Increase of Previously Announced Private Placement Financing of Convertible Debenture Units to up to $100 Million

09/01/2018 - 00:12

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION TO UNITED STATES VANCOUVER, British Columbia, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX.V: [...]

BioSyent Announces Changes to Its Board of Directors

09/01/2018 - 00:09

TORONTO, Jan. 08, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”) (TSX Venture:RX) today announced the retirement of two long-serving Directors, Mr. Douglas Larson and Mr. Milton Wakefield, from its Board of [...]

Compass Cannabis Clinics and Starbuds Announce Canadian Joint Venture

08/01/2018 - 23:58

CALGARY, Alberta, Jan. 08, 2018 (GLOBE NEWSWIRE) -- 10330698 Canada Ltd. (dba Compass Cannabis Clinics (" Compass Cannabis " or the " Company ")) is pleased to announce that it has signed a binding letter agreement with [...]

Adamas Announces U.S. Commercial Launch of GOCOVRI™ the First and Only FDA-approved Medication for the Treatment of Dyskinesia in Parkinson’s Disease Patients

08/01/2018 - 22:41

EMERYVILLE, Calif., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS ) today announced the full commercial launch of its flagship product, GOCOVRI™ (amantadine) extended release capsules, for [...]

ConforMIS Reports Preliminary Fourth Quarter and Year-End 2017 Revenue Results; Provides 2018 Financial Guidance

08/01/2018 - 22:15

BILLERICA, Mass., Jan. 08, 2018 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ: CFMS ), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell [...]

Tabula Rasa HealthCare to Participate in the 20th Annual Needham Growth Conference

08/01/2018 - 21:00

MOORESTOWN, N.J., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ: TRHC ), a healthcare technology company optimizing medication safety by deploying new medication risk mitigation digital [...]

Sarepta Therapeutics Pre-Announces Fourth Quarter 2017 Revenue and Provides Full-Year 2018 Revenue Guidance for EXONDYS 51® (eteplirsen), Representing Approximately 100 Percent Year-over-Year Growth

08/01/2018 - 19:42

-- Fourth quarter 2017 EXONDYS 51 unaudited revenue of $57.3 million -- -- Full-year 2017 EXONDYS 51 unaudited revenue of $154.6 million -- -- Full-year 2018 EXONDYS 51 revenue guidance of $295 – $305 million -- -- 16 [...]

Vaccinex, Inc. Announces Research Collaboration Employing ActivMAb® Platform Technology and Antibody License Option Agreement with Surface Oncology

08/01/2018 - 19:10

ROCHESTER, N.Y., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Vaccinex, Inc., a privately-held clinical-stage biotechnology company engaged in the development of therapeutic monoclonal antibodies to treat patients with cancer and [...]

I-MED Pharma partners with OCuSOFT to bring the I-PEN® Osmolarity System to the U.S.A.

08/01/2018 - 19:02

MONTREAL, Jan. 08, 2018 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is pleased to announce the signing of an exclusive agreement with OCuSOFT Inc. for [...]

Nuvectra™ Announces Preliminary Unaudited Fourth Quarter and Full Year 2017 Revenue

08/01/2018 - 14:00

PLANO, Texas, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR ), a neurostimulation medical device company, today announced preliminary unaudited revenue for the fourth quarter and full year ended [...]